Related Experiment Video
Updated: Dec 10, 2025

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
Published on: May 3, 2024
Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials
Junwei Zhao1, Federica Santino1, Daria Giacomini1
1Department of Chemistry "G. Ciamician", University of Bologna, via Selmi 2, 40126 Bologna, Italy.
Abstract:
Integrins are a family of cell surface receptors crucial to fundamental cellular functions such as adhesion, signaling, and viability, deeply involved in a variety of diseases, including the initiation and progression of cancer, of coronary, inflammatory, or autoimmune diseases. The natural ligands of integrins are glycoproteins expressed on the cell surface or proteins of the extracellular matrix. For this reason, short peptides or peptidomimetic sequences that reproduce the integrin-binding motives have attracted much attention as potential drugs. When challenged in clinical trials, these peptides/peptidomimetics let to contrasting and disappointing results. In the search for alternative utilizations, the integrin peptide ligands have been conjugated onto nanoparticles, materials, or drugs and drug carrier systems, for specific recognition or delivery of drugs to cells overexpressing the targeted integrins. Recent research in peptidic integrin ligands is exploring new opportunities, in particular for the design of nanostructured, micro-fabricated, cell-responsive, stimuli-responsive, smart materials.
Insights
Integrin peptide ligands show promise when conjugated to nanoparticles for targeted drug delivery, overcoming limitations seen in earlier clinical trials. This approach enables specific recognition and delivery to cells overexpressing integrins, opening new avenues in nanomedicine.
Area of Science:
- Biochemistry
- Cell Biology
- Nanomedicine
Background:
- Integrins are cell surface receptors vital for cell adhesion, signaling, and survival.
- Integrin dysregulation is implicated in cancer, cardiovascular, inflammatory, and autoimmune diseases.
- Natural integrin ligands are cell surface glycoproteins or extracellular matrix proteins.
Purpose of the Study:
- To explore alternative applications for integrin peptide ligands beyond direct therapeutic use.
- To investigate the conjugation of integrin peptide ligands onto nanoparticles for targeted drug delivery.
- To identify new opportunities in designing advanced materials using integrin ligands.
Main Methods:
- Conjugation of short peptides/peptidomimetics mimicking integrin-binding motifs onto nanoparticles.
- Utilizing these conjugates for specific recognition and drug delivery to cells overexpressing target integrins.
- Exploring the design of nanostructured and stimuli-responsive materials.
Main Results:
- Peptide/peptidomimetic ligands conjugated to nanoparticles offer improved targeting capabilities.
- This strategy circumvents the disappointing clinical trial results of earlier peptide-based therapies.
- New applications are emerging in smart materials and nanomedicine.
Conclusions:
- Conjugating integrin peptide ligands to nanoparticles is a promising strategy for targeted drug delivery.
- This approach addresses limitations of previous integrin-targeting peptide therapies.
- Future research focuses on nanostructured, responsive materials for advanced applications.
Related Concept Videos
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Intracellular Signaling Affects Focal Adhesions
Some...
Overview of Cell-Matrix Interactions

